Roble Belko & Company’s MetLife MET Stock Holding History

Roble Belko & Company’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Hold	1,430	–	–	0.01%	162
2026 Q1	$101K	Hold	1,430	–	–	0.01%	166
2025 Q4	$113K	Hold	1,430	–	–	0.01%	162
2025 Q3	$118K	Hold	1,430	–	–	0.02%	130
2025 Q2	$115K	Buy	+1,430	New	+$110K	0.02%	133
2020 Q4	–	Sell	-740	Closed	-$28K	–	325
2020 Q3	$28K	Hold	740	–	–	0.01%	167
2020 Q2	$27K	Hold	740	–	–	0.01%	177
2020 Q1	$23K	Hold	740	–	–	0.01%	185
2019 Q4	$38K	Hold	740	–	–	0.01%	168
2019 Q3	$35K	Hold	740	–	–	0.01%	164
2019 Q2	$37K	Sell	740 -179	-19%	-$8.41K	0.01%	160
2019 Q1	$39K	Hold	919	–	–	0.01%	128
2018 Q4	$38K	Buy	919 +740	+413%	+$31.8K	0.01%	120
2018 Q3	$8K	Hold	179	–	–	﹤0.01%	237
2018 Q2	$8K	Hold	179	–	–	﹤0.01%	247
2018 Q1	$8K	Hold	179	–	–	﹤0.01%	257
2017 Q4	$9K	Hold	179	–	–	﹤0.01%	237
2017 Q3	$9K	Sell	179 -22	-11%	-$1.07K	﹤0.01%	198
2017 Q2	$10K	Hold	201	–	–	﹤0.01%	188
2017 Q1	$9K	Hold	201	–	–	﹤0.01%	213
2016 Q4	$10K	Buy	+201	New	+$9.22K	0.01%	208
2016 Q3	–	Sell	-103	Closed	-$4K	–	310
2016 Q2	$4K	Hold	103	–	–	﹤0.01%	219
2016 Q1	$4K	Buy	+103	New	+$3.85K	﹤0.01%	208

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Roble Belko & Company's MET Position: Q2 2026 in Review

Roble Belko & Company held its MetLife (MET) position steady in Q2 2026 at 1,430 shares worth $121K. The position accounts for 0.01% of the portfolio, ranked #162.

Roble Belko & Company first reported a position in MET in Q1 2016 and has held it in 23 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

Roble Belko & Company held 1,430 shares of MetLife worth $121K as of Q2 2026.
Roble Belko & Company left its MetLife share count unchanged in Q2 2026.
MetLife made up 0.01% of Roble Belko & Company's portfolio in Q2 2026, its #162 holding.
Roble Belko & Company first reported a position in MetLife in Q1 2016 and has held it in 23 quarters since.
1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.